YÜKSEL, M. Et Al. 2017. A biosimilar G-CSF filgrastim is as effective as refrence drug however it is not as cost effective as it supposed to be and by the way no imapct on health care system.. 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation , (Marseille, France).

YÜKSEL, M., PEKCAN, G., ŞAHİN, U., CİVRİZ BOZDAĞ, S., TOPRAK, S. K., TOPÇUOĞLU, P., ... ARSLAN, Ö.(2017). A biosimilar G-CSF filgrastim is as effective as refrence drug however it is not as cost effective as it supposed to be and by the way no imapct on health care system. . 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, Marseille, France

YÜKSEL, MELTEM Et Al. "A biosimilar G-CSF filgrastim is as effective as refrence drug however it is not as cost effective as it supposed to be and by the way no imapct on health care system.," 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, Marseille, France, 2017

YÜKSEL, MELTEM Et Al. "A biosimilar G-CSF filgrastim is as effective as refrence drug however it is not as cost effective as it supposed to be and by the way no imapct on health care system.." 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation , Marseille, France, 2017

YÜKSEL, M. Et Al. (2017) . "A biosimilar G-CSF filgrastim is as effective as refrence drug however it is not as cost effective as it supposed to be and by the way no imapct on health care system.." 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation , Marseille, France.

@conferencepaper{conferencepaper, author={MELTEM YÜKSEL Et Al. }, title={A biosimilar G-CSF filgrastim is as effective as refrence drug however it is not as cost effective as it supposed to be and by the way no imapct on health care system.}, congress name={43rd Annual Meeting of the European Society for Blood and Marrow Transplantation}, city={Marseille}, country={France}, year={2017}}